
Global health company M42 and private equity firm Olive Rock Partners (ORP) have signed an agreement that will see the …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

